Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0TAYNY
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
H14A043-ATAC
|
|||||
| Synonyms |
H14A043ATAC; h14A043 ATAC; h14A043-Antibody Targeted Amanitin Conjugate
Click to Show/Hide
|
|||||
| Organization |
Chiome Bioscience, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Prostate cancer [ICD11:2C82]
Clinical candidate
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Antibody Name |
Human Anti-CDCP1 h14A043-ATAC mAb
|
Antibody Info | ||||
| Antigen Name |
CUB domain-containing protein 1 (CDCP1)
|
Antigen Info | ||||
| Payload Name |
Alpha-amanitin
|
Payload Info | ||||
| Therapeutic Target |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.